TY - JOUR
T1 - Prediction of haemodynamics after interatrial shunt for heart failure using the generalized circulatory equilibrium
AU - Nishikawa, Takuya
AU - Saku, Keita
AU - Uike, Kiyoshi
AU - Uemura, Kazunori
AU - Sunagawa, Genya
AU - Tohyama, Takeshi
AU - Yoshida, Keimei
AU - Kishi, Takuya
AU - Sunagawa, Kenji
AU - Tsutsui, Hiroyuki
N1 - Funding Information:
Nishikawa T., Uike K., Uemura K., Tohyama T., and Yoshida K. have nothing to declare. Saku K. and Kishi T. worked in a department endowed by Omron Healthcare Co. Saku K. received honoraria from Japan ABIOMED Inc. Sunagawa K. worked in a department endowed by Omron Healthcare Co. and Actelion Pharmaceuticals Japan. Tsutsui H. received honoraria from Daiichi Sankyo, Inc., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Mitsubishi Tanabe Pharma Corporation, Boehringer Ingelheim Japan, Inc., Novartis Pharma K.K., Bayer Yakuhin, Ltd., Bristol‐Myers Squibb KK, and Astellas Pharma Inc., and research funding from Omron Healthcare Co, Actelion Pharmaceuticals Japan, Daiichi Sankyo, Inc., and Astellas Pharma Inc.
Funding Information:
This work was supported by Research and Development of Supportive Device Technology for Medicine Using ICT (18he1102003h0004), AMED‐SENTAN; Development of Advanced Measurement and Analysis Systems (18hm0102041h0003), Grant‐in‐Aid for Early‐Career Scientists (18K15893, 19K20690, and 19K17529) from the Japan Society for the Promotion of Science, the research grant from Omron Healthcare Co., and the Japan Foundation for Applied Enzymology (VBIC: Vascular Biology of Innovation).
Publisher Copyright:
© 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Aims: Interatrial shunting (IAS) reduces left atrial pressure in patients with heart failure. Several clinical trials reported that IAS improved the New York Heart Association score and exercise capacity. However, its effects on haemodynamics vary depending on shunt size, cardiovascular properties, and stressed blood volume. To maximize the benefit of IAS, quantitative prediction of haemodynamics under IAS in individual patients is essential. The generalized circulatory equilibrium framework determines circulatory equilibrium as the intersection of the cardiac output curve and the venous return surface. By incorporating IAS into the framework, we predict the impact of IAS on haemodynamics. Methods and results: In seven mongrel dogs, we ligated the left anterior descending artery and created impaired cardiac function with elevated left atrial pressure (baseline: 7.8 ± 1.0 vs. impaired: 11.9 ± 3.2 mmHg). We established extracorporeal left-to-right atrial shunting with a centrifugal pump. After recording pre-IAS haemodynamics, we changed IAS flow stepwise to various levels and measured haemodynamics under IAS. To predict the impact of IAS on haemodynamics, we modelled the fluid mechanics of IAS by Newton's second law and incorporated IAS into the generalized circulatory equilibrium framework. Using pre-IAS haemodynamic data obtained from the dogs, we predicted the impact of IAS flow on haemodynamics under IAS condition using a set of equations. We compared the predicted haemodynamic data with those measured. The predicted pulmonary flow [r2 = 0.88, root mean squared error (RMSE) 11.4 mL/min/kg, P ' 0.001), systemic flow (r2 = 0.92, RMSE 11.2 mL/min/kg, P ' 0.001), right atrial pressure (r2 = 0.92, RMSE 0.71 mmHg, P ' 0.001), and left atrial pressure (r2 = 0.83, RMSE 0.95 mmHg, P ' 0.001) matched well with those measured under normal and impaired cardiac function. Using this framework, we further performed a simulation study to examine the haemodynamic benefit of IAS in heart failure with preserved ejection fraction. We simulated the IAS haemodynamics under volume loading and exercise conditions. Volume loading and exercise markedly increased left atrial pressure. IAS size-dependently attenuated the increase in left atrial pressure in both volume loading and exercise. These results indicate that IAS improves volume and exercise intolerance. Conclusions: The framework developed in this study quantitatively predicts the haemodynamic impact of IAS. Simulation study elucidates how IAS improve haemodynamics under volume loading and exercise conditions. Quantitative prediction of IAS haemodynamics would contribute to maximizing the benefit of IAS in patients with heart failure.
AB - Aims: Interatrial shunting (IAS) reduces left atrial pressure in patients with heart failure. Several clinical trials reported that IAS improved the New York Heart Association score and exercise capacity. However, its effects on haemodynamics vary depending on shunt size, cardiovascular properties, and stressed blood volume. To maximize the benefit of IAS, quantitative prediction of haemodynamics under IAS in individual patients is essential. The generalized circulatory equilibrium framework determines circulatory equilibrium as the intersection of the cardiac output curve and the venous return surface. By incorporating IAS into the framework, we predict the impact of IAS on haemodynamics. Methods and results: In seven mongrel dogs, we ligated the left anterior descending artery and created impaired cardiac function with elevated left atrial pressure (baseline: 7.8 ± 1.0 vs. impaired: 11.9 ± 3.2 mmHg). We established extracorporeal left-to-right atrial shunting with a centrifugal pump. After recording pre-IAS haemodynamics, we changed IAS flow stepwise to various levels and measured haemodynamics under IAS. To predict the impact of IAS on haemodynamics, we modelled the fluid mechanics of IAS by Newton's second law and incorporated IAS into the generalized circulatory equilibrium framework. Using pre-IAS haemodynamic data obtained from the dogs, we predicted the impact of IAS flow on haemodynamics under IAS condition using a set of equations. We compared the predicted haemodynamic data with those measured. The predicted pulmonary flow [r2 = 0.88, root mean squared error (RMSE) 11.4 mL/min/kg, P ' 0.001), systemic flow (r2 = 0.92, RMSE 11.2 mL/min/kg, P ' 0.001), right atrial pressure (r2 = 0.92, RMSE 0.71 mmHg, P ' 0.001), and left atrial pressure (r2 = 0.83, RMSE 0.95 mmHg, P ' 0.001) matched well with those measured under normal and impaired cardiac function. Using this framework, we further performed a simulation study to examine the haemodynamic benefit of IAS in heart failure with preserved ejection fraction. We simulated the IAS haemodynamics under volume loading and exercise conditions. Volume loading and exercise markedly increased left atrial pressure. IAS size-dependently attenuated the increase in left atrial pressure in both volume loading and exercise. These results indicate that IAS improves volume and exercise intolerance. Conclusions: The framework developed in this study quantitatively predicts the haemodynamic impact of IAS. Simulation study elucidates how IAS improve haemodynamics under volume loading and exercise conditions. Quantitative prediction of IAS haemodynamics would contribute to maximizing the benefit of IAS in patients with heart failure.
UR - http://www.scopus.com/inward/record.url?scp=85088963379&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088963379&partnerID=8YFLogxK
U2 - 10.1002/ehf2.12935
DO - 10.1002/ehf2.12935
M3 - Article
C2 - 32750231
AN - SCOPUS:85088963379
SN - 2055-5822
VL - 7
SP - 3075
EP - 3085
JO - ESC heart failure
JF - ESC heart failure
IS - 5
ER -